BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9476064)

  • 1. The value of the prognostic factors in ovarian granulosa cell tumors.
    Wabersich J; Fracas M; Mazzer S; Marchetti M; Altavilla G
    Eur J Gynaecol Oncol; 1998; 19(1):69-72. PubMed ID: 9476064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
    Costa MJ; Walls J; Ames P; Roth LM
    Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of p53 expression in ovarian granulosa cell tumors.
    Ala-Fossi SL; Mäenpää J; Aine R; Koivisto P; Koivisto AM; Punnonen R
    Gynecol Oncol; 1997 Sep; 66(3):475-9. PubMed ID: 9299263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature.
    Auranen A; Sundström J; Ijäs J; Grénman S
    Int J Gynecol Cancer; 2007; 17(5):1011-8. PubMed ID: 17374124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary.
    Villella J; Herrmann FR; Kaul S; Lele S; Marchetti D; Natiella J; Odunsi K; Mhawech-Fauceglia P
    Int J Gynecol Pathol; 2007 Apr; 26(2):154-9. PubMed ID: 17413982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.
    Railo M; Lundin J; Haglund C; von Smitten K; von Boguslawsky K; Nordling S
    Acta Oncol; 1997; 36(4):369-74. PubMed ID: 9247096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression, DNA ploidy and mitotic index as prognostic factors in patients with epithelial ovarian carcinoma.
    Ceccaroni M; Chieco P; Alboni C; De Laco P; Pagano K; Ceccarelli C; Santini D; Taroni B; Pelusi G
    Tumori; 2004; 90(6):600-6. PubMed ID: 15762364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.
    Pinto AE; Monteiro P; Silva G; Ayres JV; Soares J
    Int J Biol Markers; 2005; 20(4):249-56. PubMed ID: 16398407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of Ki-67, mutant suppressor gene p53 and low mitotic levels in defining the prognosis for adult granulosa cell tumor of the ovary].
    Volkova AV; Chepik OF; Bakhidze EV; Ten VP
    Vopr Onkol; 2005; 51(4):455-9. PubMed ID: 16308978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in ovarian adult granulosa cell tumour.
    Miller K; McCluggage WG
    J Clin Pathol; 2008 Aug; 61(8):881-4. PubMed ID: 18663055
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
    Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
    Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of DNA ploidy and p53 in early stages of epithelial ovarian carcinoma.
    Skirnisdóttir I; Sorbe B; Karlsson M; Seidal T
    Int J Oncol; 2001 Dec; 19(6):1295-302. PubMed ID: 11713603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index.
    Chen YT; Henk MJ; Carney KJ; Wong WD; Rothenberger DA; Zheng T; Feygin M; Madoff RD
    J Gastrointest Surg; 1997; 1(3):266-72; discussion 273. PubMed ID: 9834357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer.
    Uzoaru I; Rubenstein M; Mirochnik Y; Slobodskoy L; Shaw M; Guinan P
    J Surg Oncol; 1998 Jan; 67(1):33-7. PubMed ID: 9457254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of inhibin in the identification of granulosa cell tumors of the ovary.
    Hildebrandt RH; Rouse RV; Longacre TA
    Hum Pathol; 1997 Dec; 28(12):1387-95. PubMed ID: 9416696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA ploidy determination with flow cytometry, Ki-67 index and overexpression of p53 protein in 121 T1 superficial bladder carcinomas. Retrospective studies. Part II: Prognostic value and usefulness in the indication for prophylactic treatment with BCG].
    Moyano Calvo JL; De Miguel Rodríguez M; Poyato Galán JM; Ortíz Gamiz A; Molina Carranza A; Zerpa Railey JJ; Toro Cepeda H; Sánchez-Barriga Peña D; Galera Davidson H; Castiñeiras Fernández J
    Actas Urol Esp; 2001 Jan; 25(1):32-45. PubMed ID: 11284366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer.
    Mørkve O; Halvorsen OJ; Stangeland L; Gulsvik A; Laerum OD
    Int J Cancer; 1992 Dec; 52(6):851-5. PubMed ID: 1334053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.